Back
  1. Home
  2. Profile of Marine Bellefroid (ULiège)
Profil

Bellefroid Marine

Main Referenced Co-authors
Cataldo, Didier  (7)
Noël, Agnès  (7)
Rocks, Natacha  (6)
Gérard, Catherine  (5)
Sepult, Christelle  (5)
Main Referenced Keywords
ADAM (1); ADAM28 (1); adam28 (1); cancer (1); cd8 lymphocyte (1);
Main Referenced Unit & Research Centers
LBTD (1)
Main Referenced Disciplines
Oncology (9)
Biochemistry, biophysics & molecular biology (1)

Publications (total 10)

The most downloaded
193 downloads
Sepult, C., Bellefroid, M., Rocks, N., Donati, K., Gérard, C., Gilles, C., Ludwig, A., Duysinx, B., Noël, A., & Cataldo, D. (2019). ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene. doi:10.1038/s41388-018-0669-2 https://hdl.handle.net/2268/233016

The most cited

19 citations (Scopus®)

Sepult, C., Bellefroid, M., Rocks, N., Donati, K., Gérard, C., Gilles, C., Ludwig, A., Duysinx, B., Noël, A., & Cataldo, D. (2019). ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene. doi:10.1038/s41388-018-0669-2 https://hdl.handle.net/2268/233016

Gerardelli, L., Bellefroid, M., Sepult, C., Vanwinge, C., Noël, A., & CATALDO, D. (26 May 2021). Implication of CCL5-CCR5 axis in malignant pleural mesothelioma chemoresistance [Paper presentation]. GSK Pulmonology Awards 2021.

Gerardelli, L., Bellefroid, M., Sepult, C., Vanwinge, C., Noël, A., & CATALDO, D. (08 May 2021). Implication of CCL5-CCR5 axis in Malignant Pleural Mesothelioma Chemoresistance [Poster presentation]. International Mesothelioma Interest Group (iMig).

Sepult, C., Bellefroid, M., Rocks, N., Donati, K., Gérard, C., Gilles, C., Ludwig, A., Duysinx, B., Noël, A., & Cataldo, D. (2019). ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene. doi:10.1038/s41388-018-0669-2
Peer Reviewed verified by ORBi

Gérard, C., Rocks, N., Carnet, O., Hubeau, C., Bellefroid, M., Moser, M., Noël, A., & Cataldo, D. (01 July 2018). Anti-metastatic effect of ADAM28 derived from the microenvironment [Poster presentation]. 25ième Congrès de l'European association for cancer research, Amsterdam, Netherlands.

Bellefroid, M., Sepult, C., Rocks, N., Donati, K., Gerard, C., DUYSINX, B., Noël, A., & Cataldo, D. (03 May 2018). Implication of ADAM10 protease in malignant pleural mesothelioma [Paper presentation]. 14th international conference of the international mesothelioma interest group, Ottawa, Canada.

Sepult, C., Bellefroid, M., Rocks, N., donati, K., Gérard, C., DUYSINX, B., Noël, A., & Cataldo, D. (09 March 2018). Implication of ADAM10 protease in malignant mesohelioma [Poster presentation]. Lung Science Conference 2018.

Bellefroid, M. (01 February 2018). Understanding mesothelioma chemoresistance and implication of ADAM in this process [Poster presentation]. Marine Bellefroid, Bruxelles, Belgium.

Bellefroid, M. (27 January 2018). Role of ADAM proteases in mesothelioma chemoresistance [Poster presentation]. BACR, Liège, Belgium.

Gérard, C., Hubeau, C., Carnet, O., Bellefroid, M., Sounni, N. E., Blacher, S., Bendavid, G., Moser, M., Fässler, R., Noël, A., Cataldo, D.* , & Rocks, N.*. (2018). Microenvironment-derived ADAM28 prevents cancer dissemination. Oncotarget, 9 (98), 37185-37199. doi:10.18632/oncotarget.26449
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Gérard, C., Rocks, N., Carnet, O., Hubeau, C., & Bellefroid, M. (October 2016). ADAM28 - Generation of a conditional ADAM28 knock-out mouse Implication of ADAM28 in metastasis dissemination [Poster presentation]. 12ieme Journées de Recherche Respiratoire J2R, Nice, France.

Contact ORBi